Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of rilzabrutinib in adults with Graves' disease. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease

Drugs mentioned

• Rilzabrutinib (rilzabrutinib)

Snippet

Sponsor: Sanofi | Conditions: Graves' Disease | Phase 2 | Status: RECRUITING